Britannia Life Sciences Inc. (CSE:BLAB)
0.0900
+0.0050 (5.88%)
Dec 4, 2025, 5:26 PM EST
Revenue by Product
Fiscal year is April - March.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Nov '20 Nov 30, 2020 | 2015 - 2019 |
| Management Fees | 154.84K |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Management Fees Growth | -18.41% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Manufacturing and Packaging | 114.59K |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Manufacturing and Packaging Growth | -37.30% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Laboratory Testing | 99.85K |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Laboratory Testing Growth | -97.52% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Safety and Other Compliance | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Safety and Other Compliance Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Online | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Online Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is April - March.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Nov '20 Nov 30, 2020 | 2015 - 2019 |
| Canada | 369.28K |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Canada Growth | -95.12% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| United States | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| United States Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|